Management of immune thrombocytopenic purpura in adults J. Bussel, New York, United States of America
- Biography
English - 2008-06-13 Topic: Platelet Disorders
Speaker Disclosure
Research Support / P.I: Amgen, Glaxo Smith Kline, MGI Pharma, Ligand, others
Employee: N/A
Consultant / Scientific Advisory Board: Amgen, Glaxo Smith Kline, Ligand, Baxter
Major Stockholder: Amgen, Glaxo Smith Kline (trust and IRA not under JBB control)
Speakers’ Bureau: Amgen, Baxter, Sysmex, Scienta
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
- 
